A Pilot Study on the Safety of a Novel Antioxidant Nanoparticle Delivery System and Its Indirect Effects on Cytokine Levels in Four Dogs.

antioxidant canine catalase nanoparticle spinal cord injury superoxide dismutase

Journal

Frontiers in veterinary science
ISSN: 2297-1769
Titre abrégé: Front Vet Sci
Pays: Switzerland
ID NLM: 101666658

Informations de publication

Date de publication:
2020
Historique:
received: 21 04 2020
accepted: 19 06 2020
entrez: 28 8 2020
pubmed: 28 8 2020
medline: 28 8 2020
Statut: epublish

Résumé

Acute spinal cord injury consists of a primary, traumatic event followed by a cascade of secondary events resulting in ongoing cell damage and death. There is great interest in prevention of these secondary effects to reduce permanent long-term neurologic deficits. One such target includes reactive oxygen species released following injury, which can be enzymatically converted into less harmful molecules by superoxide dismutase and catalase. Canine intervertebral disc herniation has been suggested as a naturally occurring model for acute spinal cord injury and its secondary effects in people. The aims of this study were to test the safety of a novel antioxidant delivery system in four healthy dogs and to indirectly test effect of delivery via cytokine measurement. All dogs experienced adverse events to some degree, with two experiencing adverse events considered to be severe. The clinical signs, including combinations of bradycardia, hypotension, hypersalivation, pale gums, and involuntary urination, were consistent with complement activation-related pseudoallergy (CARPA). CARPA is a well-known phenomenon that has been reported to occur with nanoparticle-based drug delivery, among other documented causes. Two dogs also had mild to moderate changes in their blood cell count and chemistry, including elevated alanine transferase, and thrombocytopenia, which both returned to normal by day 7 post-administration. Cytokine levels trended downwards over the first 3 days, but many were elevated at measurement on day 7. Intradermal testing suggested catalase as a potential cause for reactions. No long-term clinical signs were observed, and necropsy results revealed no concerning pathology. Additional evaluation of this product, including further characterization of reactions to catalase containing components, dose-escalation, and desensitization should be performed before evaluation in clinically affected dogs.

Identifiants

pubmed: 32851027
doi: 10.3389/fvets.2020.00447
pmc: PMC7406565
doi:

Types de publication

Journal Article

Langues

eng

Pagination

447

Informations de copyright

Copyright © 2020 Robinson, Platt, Bibi, Banovic, Barber, Howerth and Madsen.

Références

Cell Death Dis. 2013 Nov 07;4:e903
pubmed: 24201802
Biomed Mater. 2018 Feb 08;13(2):024105
pubmed: 29155409
Nat Rev Dis Primers. 2017 Apr 27;3:17018
pubmed: 28447605
J Allergy Clin Immunol Pract. 2020 Jan;8(1):267-272
pubmed: 31408712
J Allergy Clin Immunol. 1984 Oct;74(4 Pt 2):600-5
pubmed: 6491107
Neuroscience. 2004;126(2):285-95
pubmed: 15207346
Neuroepidemiology. 2010;34(3):184-92; discussion 192
pubmed: 20130419
J Neurotrauma. 2004 Oct;21(10):1355-70
pubmed: 15672627
Vet Immunol Immunopathol. 2016 Oct 15;179:32-5
pubmed: 27590423
Clin Transl Immunology. 2015 Jul 17;4(7):e39
pubmed: 26246897
Pharmacology. 2018;101(1-2):104-110
pubmed: 29136631
JAMA. 2015 Jun 9;313(22):2236-43
pubmed: 26057284
Prog Neurobiol. 2014 Mar;114:25-57
pubmed: 24269804
J Neurotrauma. 2012 Mar 20;29(5):1000-11
pubmed: 21599492
Drug Deliv Transl Res. 2011 Dec 1;1(6):409-19
pubmed: 22201014
Ann Oncol. 2003 Sep;14(9):1430-7
pubmed: 12954584
Nat Nanotechnol. 2018 Dec;13(12):1100-1108
pubmed: 30348955
J Allergy Clin Immunol. 2009 Oct;124(4):786-92.e4
pubmed: 19767073
Front Cell Neurosci. 2016 Apr 13;10:98
pubmed: 27147970
J Vet Sci. 2003 Apr;4(1):97-101
pubmed: 12819372
Front Biosci. 1997 Jun 01;2:d232-41
pubmed: 9195895
J Neurosurg. 1992 Jan;76(1):23-31
pubmed: 1727165
Vet Dermatol. 2018 Jun;29(3):250-e93
pubmed: 29512229
Vet Dermatol. 2010 Feb;21(1):70-9
pubmed: 20187913
J Vet Intern Med. 2016 Jan-Feb;30(1):206-14
pubmed: 26520829
Vet Pathol. 2018 Jan;55(1):53-67
pubmed: 28812527
Curr Allergy Asthma Rep. 2004 Jan;4(1):25-30
pubmed: 14680617
J Control Release. 2019 May 28;302:160-168
pubmed: 30930216
World Neurosurg. 2017 Feb;98:438-443
pubmed: 27876663
Vet Dermatol. 2019 Aug;30(4):325-e91
pubmed: 31038263
Spinal Cord. 2006 Oct;44(10):584-93
pubmed: 16520817
Front Immunol. 2015 Jun 02;6:262
pubmed: 26082779
Adv Drug Deliv Rev. 2012 Dec;64(15):1706-16
pubmed: 22820530
Int Rev Immunol. 2013 Jun;32(3):249-70
pubmed: 23617726
Spinal Cord. 2014 Feb;52(2):110-6
pubmed: 23439068
Am J Physiol. 1999 Jan;276(1):L146-54
pubmed: 9887067
Allergy. 2009 Feb;64(2):234-41
pubmed: 19178403
Spine (Phila Pa 1976). 2001 Dec 15;26(24 Suppl):S2-12
pubmed: 11805601
J Spinal Disord Tech. 2012 May;25(3):E81-7
pubmed: 22134733
J Liposome Res. 2007;17(2):107-17
pubmed: 17613700
Mol Immunol. 2014 Oct;61(2):163-73
pubmed: 25124145
Nanoscale. 2015 Apr 14;7(14):6045-58
pubmed: 25766431
Adv Drug Deliv Rev. 2011 Sep 16;63(12):1020-30
pubmed: 21787819
Biochim Biophys Acta. 2012 May;1822(5):675-84
pubmed: 22080976
Ann Allergy Asthma Immunol. 2013 Apr;110(4):258-62
pubmed: 23535089
Free Radic Biol Med. 1998 Aug;25(3):298-304
pubmed: 9680175
Toxicol Pathol. 2013 Feb;41(2):280-302
pubmed: 23471185
Biomaterials. 2016 Mar;81:169-180
pubmed: 26735970
Nanomedicine. 2016 May;12(4):933-943
pubmed: 26767512
J Biomater Sci Polym Ed. 2006;17(3):247-89
pubmed: 16689015
J Transl Med. 2018 Sep 17;16(1):258
pubmed: 30223849
Vet J. 2017 Feb;220:7-16
pubmed: 28190499
Vet Parasitol. 2008 Dec 10;158(3):171-6
pubmed: 18977090
J Neurotrauma. 2016 Mar 1;33(5):468-81
pubmed: 26529320
J Cell Mol Med. 2017 May;21(5):941-954
pubmed: 27957787
Spine (Phila Pa 1976). 2000 Jul 15;25(14):1859-66
pubmed: 10888960
J Control Release. 2014 Dec 10;195:2-10
pubmed: 25148822
Global Spine J. 2017 Sep;7(3 Suppl):203S-211S
pubmed: 29164025
FASEB J. 2009 May;23(5):1384-95
pubmed: 19124559
Toxicology. 2005 Dec 15;216(2-3):106-21
pubmed: 16140450
Vet Immunol Immunopathol. 2001 Sep 20;81(3-4):289-304
pubmed: 11553391
J Neurotrauma. 2015 Nov 1;32(21):1674-83
pubmed: 26065706
J Neurosurg. 1993 Oct;79(4):500-7
pubmed: 8410217

Auteurs

Kelsey Robinson (K)

Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA, United States.

Simon Platt (S)

Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA, United States.

Katherine Bibi (K)

Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA, United States.

Frane Banovic (F)

Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA, United States.

Renee Barber (R)

Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA, United States.

Elizabeth W Howerth (EW)

Department of Pathology, College of Veterinary Medicine, University of Georgia, Athens, GA, United States.

Gary Madsen (G)

ProTransit Nanotherapy, LLC, Omaha, NE, United States.

Classifications MeSH